Patrick Wood
Stock Analyst at Morgan Stanley
(3.10)
# 1,278
Out of 5,072 analysts
109
Total ratings
47.5%
Success rate
1.98%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $17 | $21.03 | -19.14% | 5 | Nov 10, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $89 → $63 | $63.47 | -0.74% | 9 | Nov 10, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $79.99 | +0.01% | 8 | Oct 30, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $125 → $130 | $101.58 | +27.98% | 7 | Oct 23, 2025 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $77.93 | -2.48% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $79.31 | +0.87% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $194.02 | +1.54% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $266.28 | +10.79% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $146.31 | -15.93% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $16.19 | -19.70% | 8 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $71 → $68 | $31.68 | +114.65% | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $86.67 | -6.54% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $18.74 | +44.08% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $11.42 | -21.19% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $85.26 | +20.81% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $106.29 | -32.26% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $114.42 | +51.20% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $327.19 | -3.11% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $3.01 | +232.23% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $26.52 | +39.52% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $119.68 | - | 5 | Dec 11, 2017 |
Tandem Diabetes Care
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $13 → $17
Current: $21.03
Upside: -19.14%
DexCom
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $89 → $63
Current: $63.47
Upside: -0.74%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $79.99
Upside: +0.01%
Boston Scientific
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $101.58
Upside: +27.98%
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $77.93
Upside: -2.48%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $79.31
Upside: +0.87%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $194.02
Upside: +1.54%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $266.28
Upside: +10.79%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $146.31
Upside: -15.93%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $16.19
Upside: -19.70%
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $31.68
Upside: +114.65%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $86.67
Upside: -6.54%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $18.74
Upside: +44.08%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $11.42
Upside: -21.19%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $85.26
Upside: +20.81%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $106.29
Upside: -32.26%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $114.42
Upside: +51.20%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $327.19
Upside: -3.11%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $3.01
Upside: +232.23%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $26.52
Upside: +39.52%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $119.68
Upside: -